8. Drug allergy

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 2 SUPPL. 2, 2006, Pages

  Greenberger, Paul A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Allergy; Drug; Immunosuppressive; Keratinocytes; Penicillin; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALEMTUZUMAB; ALLOPURINOL; ALPHA INTERFERON; ANTIBIOTIC AGENT; CARBAMAZEPINE; CD3 ANTIBODY; CEPHALOSPORIN; COTRIMOXAZOLE; CREMOPHOR; CYCLOSPORIN; ETANERCEPT; IMMUNOMODULATING AGENT; INFLIXIMAB; INTERLEUKIN 2; LAMOTRIGINE; METHOTREXATE; MYCOPHENOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G DERIVATIVE; PHENOBARBITAL; PHENYTOIN; POLYSORBATE 80; RAPAMYCIN; RITUXIMAB; SULFONAMIDE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG; VANCOMYCIN;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; CARDIOVASCULAR DISEASE; CYTOKINE RELEASE; DERMATITIS; DIARRHEA; DRUG CROSS REACTIVITY; DRUG CYTOTOXICITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DYSPNEA; ECZEMA; EOSINOPHILIA; ERYTHEMA; ERYTHEMA MULTIFORME; FEVER; GLOMERULUS FILTRATION RATE; HASHIMOTO DISEASE; HEMOLYTIC ANEMIA; HEPATITIS; HEPATITIS B; HERXHEIMER REACTION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPERTRICHOSIS; HYPOTENSION; HYPOTHYROIDISM; KERATINOCYTE; LEUKOCYTOSIS; LYMPHADENOPATHY; MACULOPAPULAR RASH; MELANOMA; PRIORITY JOURNAL; RASH; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; RIGOR; SECONDARY SYPHILIS; SERUM SICKNESS; SKIN EXFOLIATION; SKIN TEST; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC EPIDERMAL NECROLYSIS; UNSPECIFIED SIDE EFFECT; URTICARIA;

EID: 31544446877     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.11.002     Document Type: Article

References (60)

1. L.C. Grammer, and P.A. Greenberger Drug allergy and protocols for management of drug allergies 3rd ed. 2003 Oceanside Pubs Providence (RI) p. 1-42
2. A.M. Ditto Drug allergy part A: introduction, epidemiology, classification of adverse reactions, immunological basis, risk factors, evaluation of patients with suspected drug allergy, patient management considerations L.C. Grammer P.A. Greenberger Patterson's allergic diseases 6th ed. 2002 Lippincott, Williams & Wilkins Philadelphia 295 334
3. T.K. Gandhi Fumbled handoffs: one dropped ball after another Ann Intern Med 142 2005 352 358
4. R. Amalberti, Y. Auroy, D. Berwick, and P. Barach Five system barriers to achieving ultrasafe health care Ann Intern Med 142 2005 756 764
5. C.L. Bennett, J.R. Nebeker, E.A. Lyons, M.H. Samore, M.D. Feldman, and J.M. McKoy The Research on Adverse Drug Events and Reports (RADAR) project JAMA 293 2005 2131 2140
6. J.H. Gurwitz, T.S. Field, L.R. Harrold, J. Rothchild, K. Debellis, and A.C. Seger Incidence and preventability of adverse drug events among older persons in the ambulatory setting JAMA 289 2003 1107 1116
7. T.J. Gandhi, S.N. Weingart, J. Borus, A.C. Seger, J. Peterson, and E. Burdick Adverse drug events in ambulatory care N Engl J Med 348 2003 1556 1564
8. A.G. Wintherstein, R.C. Hatton, R. Gonzalez-Rothi, T.E. Johns, and R. Segal Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports Am J Health Syst Pharm 59 2002 1742 1749
9. L.T. Kohn J.M. Corrigan M.S. Donaldson To err is human: building a safer health system 2000 National Academy Press Washington (DC)
10. H.S. Blix, K.K. Viktil, A. Reikvam, T.A. Moger, B.J. Hjemaas, and P. Pretsch The majority of hospitalized patients have drug-related problems: results from a prospective study in general hospitals Eur J Clin Pharmacol 60 2004 651 658
11. D.G. Ebo, G.C. Piel, V. Conraads, and W.J. Stevens IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine Ann Allergy Asthma Immunol 87 2001 243 245
12. G.W. Volcheck, and R.G. Van Dellen Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review Ann Allergy Asthma Immunol 80 1998 159 163
13. R.A. Kuiper, M.M. Malingre, J.H. Beijnen, and J.H. Schellens Cyclosporine-induced anaphylaxis Ann Pharmacother 34 2000 858 861
14. H. Wadei, S.A. Gruber, J.M. El-Amm, J. Garnick, M.S. West, and D.K. Granger Sirolimus-induced angioedema Am J Transplant 6 2004 1002 1005
15. M.A. Dimopoulos, and V. Eleutherakis-Papaiakovou Adverse effects of thalidomide administration in patients with neoplastic diseases Am J Med 117 2004 508 515
16. K. Krause, G. Valesini, R. Scrivo, and Y. Shoenfeld Autoimmune aspects of cytokine and anticytokine therapies Am J Med 115 2003 390 397
17. P.J. Charles, R.J. Smeenk, J. De Jong, M. Feldmann, and R.N. Maine Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials Arthritis Rheum 43 2000 2382 2390
18. J. Sellam, Y. Allanore, F. Batteux, C.J. Deslandre, B. Weill, and A. Kahan Autoantibody induction in patients with refractory spondyloarthropathy treated with infliximab and methotrexate Joint Bone Spine 72 2005 48 52
19. B. Guillot, L. Blazquez, D. Bessis, O. Dereure, and J.J. Guilhou A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma Dermatology 208 2004 49 54
20. U. Winkler, M. Jensen, O. Manzke, H. Schulz, V. Diehl, and A. Engert Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (Rituximab, IDEC-C2B8) Blood 94 1999 2217 2224
21. K.C. Herold, W. Hagopian, J. Auger, E. Poumian-Ruiz, L. Taylor, and D. Donaldson Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus N Engl J Med 346 2002 1692 1698
22. M. Buchler, B. Hurault de Ligny, C. Madec, and Y. Lebraanchu Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy Clin Transplant 17 2003 539 545
23. L.C. Grammer, M. Roberts, B.E. Metzger, and R. Patterson IgE against human (recombinant DNA) insulin in patients with systemic insulin allergy J Allergy Clin Immunol 73 1984 180
24. T.J. Sullivan, H.J. Wedner, G.S. Schatz, L.D. Yecies, and C.W. Parker Skin testing to detect penicillin allergy J Allergy Clin Immunol 68 1981 171 180
25. P.A. Greenberger Patterns of anti-penicillin IgE antibodies in 634 penicillin allergic patients J Invest Med 49 2001 303A
26. D. Sogn, R. Evans III, G.M. Shepherd, T.B. Casale, J. Condemi, and P.A. Greenberger Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults Arch Intern Med 152 1992 1025 1032
27. R. Solensky, H.S. Earl, and R.S. Gruchalla Penicillin allergy: prevalence of vague history in skin test-positive patients Ann Allergy Asthma Immunol 85 2000 195 199
28. E. Macy, R. Mangat, and R.J. Bruchette Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins J Allergy Clin Immunol 111 2003 1111 1115
29. A. Bittner, and P.A. Greenberger Incidence of resensitization after tolerating penicillin treatment in penicillin-allergic patients Allergy Asthma Proc 25 2004 161 164
30. P.S. Kelkar, and J.T.-C. Li Cephalosporin allergy N Engl J Med 345 2001 804 809
31. P.A. Greenberger Utility of penicillin major and minor determinants for identification of allergic reactions to cephalosporins J Allergy Clin Immunol 115 suppl 2005 S182
32. A. Romano, R.-M. Guenant-Rodriquez, M. Viola, R. Pettinato, and J.-L. Gueant Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins Ann Intern Med 141 2004 16 22
33. R.S. Gruchalla Drug allergy J Allergy Clin Immunol 111 suppl 2003 S548 S559
34. N.H. Shear, S.P. Spielberg, D.M. Grant, B.K. Tang, and W. Kalow Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity Ann Intern Med 105 1986 179 184
35. B.L. Strom, R. Schinnar, A.J. Apter, D.J. Margolis, E. Lautenbach, and S. Hennessy Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics N Engl J Med 349 2003 1628 1635
36. P.A. Greenberger Drug allergy part B: allergic reactions to individual drugs: low molecular weight L.C. Grammer P.A. Greenberger Patterson's allergic diseases 6th ed. 2002 Lippincott, Williams & Wilkins Philadelphia 335 359
37. R.R. Gollapudi, P.S. Teirstein, D.D. Stevenson, and R.A. Simon Aspirin sensitivity: implications for patients with coronary artery disease JAMA 292 2004 3017 3023
38. D.A. Mathison, W.R. Lumry, D.D. Stevenson, and J.G. Curd Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization J Allergy Clin Immunol 69 1982 135
39. N.-S. Lam, Y.-H. Yang, L.-C. Wang, Y.-T. Lin, and B.-L. Chiang Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children J Microbiol Immunol Infect 37 2004 366 370
40. B. Rzany, O. Correia, J. Kelly, L. Naldi, A. Auquier, and R. Stern Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of epileptic therapy: a case-control study Lancet 353 1999 2190 2194
41. A. Nassif, A. Bensussan, L. Boumsell, A. Deniaud, H. Moslehi, and P. Wolkenstein Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells J Allergy Clin Immunol 114 2004 1209 1215
42. I. Viard, P. Wehrli, R. Bullani, P. Schneider, N. Holler, and D. Salomon Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490 493
43. R. Abe, T. Shimizu, A. Shibaki, H. Nakamura, H. Watanabe, and H. Shimizu Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand Am J Pathol 162 2003 1515 1520
44. N. Bachot, J. Revuz, and J.-C. Roujeau Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis Arch Dermatol 139 2003 33 36
45. J.-P. Allam, T. Paus, C. Reichel, T. Bieber, and N. Novak DRESS syndrome associated with carbamazepine and phenytoin Eur J Dermatol 14 2004 339 342
46. A. Tripathi, N.T. Peters, and R. Patterson Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis L.C. Grammer P.A. Greenberger Patterson's allergic diseases 6th ed. 2002 Lippincott, Williams & Wilkins Philadelphia 289 294
47. A. Tripathi, A.M. Ditto, L.C. Grammer, P.A. Greenberger, K.G. McGrath, and C.R. Zeiss Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases Allergy Asthma Proc 21 2000 101 105
48. B.B. Levine, and D.M. Zolov Prediction of penicillin allergy by immunological tests J Allergy 43 1969 231 244
49. A. Saxon, D.C. Adelman, A. Patel, R. Hajdu, and G.B. Calandra Imipenem cross-reactivity with penicillin in humans J Allergy Clin Immunol 82 1988 213 217
50. B.R. Canaday Anticonvulsant cross-sensitivity Am J Health Syst Pharm 54 1997 2616 2617
51. N.J. Brown, M. Snowden, and M.R. Griffin Recurrent angiotensin-converting enzyme inhibitor-associated angioedema JAMA 278 1997 232 233
52. E.E. Slater, D.D. Merrill, H.A. Guess, P.J. Roylance, W.D. Cooper, and W.H.W. Inman Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition JAMA 260 1988 967 970
53. M. Samter, and R.F. Beers Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis Ann Intern Med 68 1968 975 983
54. N.F. Adkinson Jr., W.L. Thompson, W.C. Maddrey, and L.M. Lichtenstein Routine use of penicillin skin testing on an inpatient service N Engl J Med 285 1971 22 24
55. D.D. Stevenson, and R.A. Simon Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma J Allergy Clin Immunol 108 2001 47 51
56. A. Szczeklik, E. Nizankowska, G. Bochenek, K. Nagraba, F. Mejza, and M. Swierczynska Safety of a specific COX-2 inhibitor in aspirin-induced asthma Clin Exp Allergy 31 2001 219 225
57. K.M. Woessner, R.A. Simon, and D.D. Stevenson Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 93 2004 339 344
58. J. Quiralte, J. Delgado, B. Saenz de San Pedro, E. Lopez-Pascual, M.A. Nieto, and N. Ortega Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs Ann Allergy Asthma Immunol 93 2004 360 364
59. M. Cicardi, L.C. Zingale, L. Bergamaschini, and A. Agostoni Angioedema associated with angiotensin-converting enzyme inhibitor use Arch Intern Med 164 2004 910 913
60. P.A. Greenberger, and R. Patterson The prevention of immediate generalized reactions to radiocontrast media in high risk patients J Allergy Clin Immunol 87 1991 867 872